We further studied the Treg function in MF patients compared with other MPN patients and normal controls: Treg function was measured as a percentage of decrease of XTT with T response cells (CD4+CD25-) cultured with Treg cells (CD4+CD25+) and as a percentage of cultured medium alone. The gene discussed is CD4; the disease is myeloproliferative disorder.